Index of reports
> All Cases (2770)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Velcade (Bortezomib) all cases. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 2770 Next >>
Possible Velcade side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Hypotension
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalidomide
Dosage: 50 mg, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-08-06
End date: 2012-08-09
Velcade
Dosage: 1 mg/m2, unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-08-06
End date: 2012-08-09
Other drugs received by patient: Dexamethasone
Possible Velcade side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient: male, weighing 93.4 kg (205.5 pounds)
Reactions: Confusional State, Fatigue, Pseudomembranous Colitis, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Dosage: 2.95 mg, cyclic
Indication: Multiple Myeloma
Start date: 2011-02-07
End date: 2011-03-03
Decadron
Dosage: unk
Indication: Multiple Myeloma
Other drugs received by patient: Zofran; Cipro / 00042702 /; Duragesic-100; Armodafinil; Xanax; Morphine Sulfate; Miralax; Valtrex
Possible Velcade side effects in 75 year old male
Reported by a physician from United States on 2012-08-27
Patient: 75 year old male, weighing 97.0 kg (213.4 pounds)
Reactions: Anaphylactic Reaction, Atrial Fibrillation, Hyperthyroidism
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Dosage: 90 mg/m2, cyclic
Indication: Lymphoma
Start date: 2012-08-02
End date: 2012-08-06
Velcade
Dosage: 1.6 mg/m2, cyclic
Indication: Lymphoma
End date: 2012-08-06
Ofatumumab
Dosage: 300 mg, cyclic
Indication: Lymphoma
Start date: 2012-08-02
End date: 2012-08-06
Possible Velcade side effects in
Reported by a physician from France on 2012-08-27
Patient:
Reactions: Death, Arthralgia, Radiotherapy
Adverse event resulted in: death
Drug(s) suspected as cause:
Velcade
Possible Velcade side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient: male
Reactions: Abscess Neck
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Dosage: unk
Indication: Multiple Myeloma
End date: 2011-06-21
Cisplatin
Dosage: unk
Indication: Multiple Myeloma
End date: 2011-06-21
Doxorubicin Hydrochloride
Dosage: unk
Indication: Multiple Myeloma
End date: 2011-06-21
Cyclophosphamide
Dosage: unk
Indication: Multiple Myeloma
End date: 2011-06-21
Etoposide
Dosage: unk
Indication: Multiple Myeloma
End date: 2011-06-21
Possible Velcade side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Neurogenic Bladder, Neuropathy Peripheral, Syncope, Diarrhoea, Interstitial Lung Disease, Dizziness, Toxic Skin Eruption, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Dosage: 2.4 mg, unk
Indication: Multiple Myeloma
Start date: 2011-11-14
End date: 2011-11-24
Piperacillin Tazobactam
Indication: Infection
Other drugs received by patient: Mecobalamin; Lansoprazole; Uralyt / 01779901 /; Goshajinkigan; Acecol; Olopatadine HCL; Oxinorm / 00547301 /; Dexamethasone; Losartan Potassium
Possible Velcade side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male
Reactions: Portal Hypertension, Pain, Thrombocytopenia, Epistaxis, Decreased Appetite, Renal Failure Acute, Bronchopulmonary Aspergillosis, Pseudomonas Infection, Anaemia, Hyperviscosity Syndrome, Rash, Haemangioma of Spleen, Pulmonary Sepsis, Syncope, Respiratory Failure, Visual Impairment, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Velcade
Indication: Multiple Myeloma
Start date: 2012-04-17
End date: 2012-04-28
Dexamethasone Sodium Phosphate
Indication: Multiple Myeloma
Start date: 2012-03-21
End date: 2012-04-01
Doxorubicin HCL
Indication: Multiple Myeloma
Start date: 2012-03-21
End date: 2012-04-01
Dexamethasone Sodium Phosphate
Start date: 2012-03-01
End date: 2012-03-12
Lenalidomide
Indication: Multiple Myeloma
Start date: 2012-05-21
End date: 2012-06-10
Cotrim DS
Indication: Product Used FOR Unknown Indication
Doxorubicin HCL
Start date: 2012-04-17
End date: 2012-04-28
Velcade
Start date: 2012-03-21
End date: 2012-04-01
Dexamethasone Sodium Phosphate
Start date: 2012-05-21
End date: 2012-06-10
Velcade
Start date: 2012-03-01
End date: 2012-03-12
Dexamethasone Sodium Phosphate
Start date: 2012-04-17
End date: 2012-04-28
Other drugs received by patient: Acyclovir
Possible Velcade side effects in 69 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: 69 year old female, weighing 71.8 kg (158.0 pounds)
Reactions: Blood Culture Positive, Bacterial Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Temsirolimus
Dosage: 25 mg, weekly, iv
Start date: 2012-04-25
End date: 2012-08-22
Velcade
Dosage: 1.6 mg/m2, weekly iv
Start date: 2012-04-25
End date: 2012-08-22
Other drugs received by patient: Acyclovir; Hydrodiuril; Potassium Chloride; Diovan
Possible Velcade side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: male, weighing 103.1 kg (226.8 pounds)
Reactions: Plasmacytosis, Pneumonia, Mouth Haemorrhage, Pseudomonas Infection, Headache, Disease Progression, Death, Mucosal Inflammation, Pleural Effusion, Depressed Level of Consciousness, Abscess, Lethargy, RIB Fracture
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Doxorubicin Hydrochloride
Indication: Multiple Myeloma
Thalidomide
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Radiation Therapy NOS
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Revlimid
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Cisplatin
Indication: Multiple Myeloma
Other drugs received by patient: Bendamustine Hydrochloride; Lenalidomide
Possible Velcade side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Hyperkalaemia, Interstitial Lung Disease, Multiple Myeloma
Adverse event resulted in: death
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Dexamethasone; Methylprednisolone Sodium Succinate; Glucose
Possible Velcade side effects in
Reported by a physician from France on 2012-08-24
Patient:
Reactions: Malocclusion, Intestinal Obstruction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Dosage: 180 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2012-04-17
End date: 2012-07-10
Mabthera
Dosage: 750 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2012-04-17
End date: 2012-07-09
Velcade
Dosage: 2.6 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2012-04-17
End date: 2012-07-16
Other drugs received by patient: Gliclazide; Plavix; Alpresin; Lyrica
Possible Velcade side effects in male
Reported by a physician from United States on 2012-08-23
Patient: male
Reactions: Death, Chalazion
Adverse event resulted in: death
Drug(s) suspected as cause:
Lenalidomide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Velcade
Dosage: 2 mg, 1/week
Indication: Multiple Myeloma
Start date: 2009-08-13
End date: 2012-01-03
Cyclophosphamide
Indication: Multiple Myeloma
Other drugs received by patient: Bisphosphonates; Travoprost
Possible Velcade side effects in
Reported by a consumer/non-health professional from United Kingdom on 2012-08-23
Patient:
Reactions: Off Label Use, Glossodynia, Neuropathy Peripheral, Skin Sensitisation
Drug(s) suspected as cause:
Velcade
Possible Velcade side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient: male
Reactions: Drug Ineffective
Drug(s) suspected as cause:
Velcade
Possible Velcade side effects in female
Reported by a physician from United States on 2012-08-23
Patient: female
Reactions: Chalazion
Drug(s) suspected as cause:
Lenalidomide
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Velcade
Dosage: 2 mg, 1/week
Indication: Multiple Myeloma
Start date: 2008-11-13
Other drugs received by patient: Synthroid; Bisphosphonates
Possible Velcade side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient: female, weighing 77.6 kg (170.6 pounds)
Reactions: Chest Pain
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituximab
Dosage: 375 mg/m2, cyclic
Indication: Renal Transplant
Start date: 2012-01-24
End date: 2012-01-24
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Renal Transplant
Start date: 2012-01-31
End date: 2012-02-21
Other drugs received by patient: Pantoprazole; Nephrocaps; Estraderm; Gabapentin; Metoprolol Tartrate; Calcium Acetate; Epoetin; Nasonex
Possible Velcade side effects in 61 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient: 61 year old male, weighing 92.5 kg (203.5 pounds)
Reactions: Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Dosage: 2.6 mg,d1,4,8,11 q 3 weeks
Indication: Multiple Myeloma
Start date: 2011-03-07
End date: 2012-04-28
Adriamycin PFS
Dosage: 20 mg, d1 and d3 q 3 weeks
Indication: Multiple Myeloma
Start date: 2011-03-07
End date: 2011-04-25
Pamidronate Disodium
Dosage: 90 mg,d1 q 3 weeks
Indication: Osteolysis
Start date: 2011-03-07
End date: 2011-04-18
Possible Velcade side effects in male
Reported by a physician from United States on 2012-08-23
Patient: male
Reactions: Chalazion
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Multiple Myeloma
Lenalidomide
Indication: Multiple Myeloma
Velcade
Dosage: 2 mg, 1/week
Indication: Multiple Myeloma
Start date: 2010-09-13
Dexamethasone
Indication: Multiple Myeloma
Other drugs received by patient: Bisphosphonates; Doxazosin Mesylate
Possible Velcade side effects in
Reported by a physician from France on 2012-08-23
Patient:
Reactions: Back Pain, Electrocardiogram QT Prolonged, Dyspnoea, Hypotension, Thrombocytopenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Velcade
Dosage: 2.1 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
JNJ-26481585
Dosage: 12 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-21
End date: 2012-05-31
Dexamethasone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Acetaminophen; Zelitrex / 01269701 /; Fentanyl; Atracurium Besylate; Kardegic / 00002703 /; Oxycontin; Oxygen; Tranxene; Primperan / 00041901 /; Bumetanide; Crestor; Primperan / 00041901 /; Hydrocortisone; Ondansetron; Ondansetron; Ondansetron; Importal; Tramadol HCL; Noradrenaline / 00127501 /; Tramadol HCL; Morphine; Furosemide; Midazolam; Tramadol HCL
Possible Velcade side effects in
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient:
Reactions: Neuropathy Peripheral, Pneumonia, Post Herpetic Neuralgia, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, cyclic
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-10-01
Velcade
Dosage: 3.4 mg, cyclic
Indication: Multiple Myeloma
Start date: 2011-10-06
End date: 2012-02-02
Other drugs received by patient: Simvastin-Mepha; Enalapril Maleate; Aspirin; Doxazosin Mesylate; Amlodipine; Dyazide
Possible Velcade side effects in female
Reported by a pharmacist from United States on 2012-08-23
Patient: female
Reactions: Blood Parathyroid Hormone Increased
Drug(s) suspected as cause:
Velcade
Possible Velcade side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Chalazion
Drug(s) suspected as cause:
Dexamethasone
Indication: Multiple Myeloma
Velcade
Dosage: 2 mg, 1/week
Indication: Multiple Myeloma
Start date: 2009-04-01
End date: 2011-02-10
Cyclophosphamide
Indication: Multiple Myeloma
Lenalidomide
Indication: Multiple Myeloma
Other drugs received by patient: Zocor; Aredia; Actonel; Bisphosphonates; Lasix; Multi Vitamin and Mineral + Selenium; Comadin
Possible Velcade side effects in
Reported by a physician from Canada on 2012-08-23
Patient:
Reactions: Cardiac Disorder
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Decadron; Cyclophosphamide
Possible Velcade side effects in 17 year old male
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient: 17 year old male, weighing 89.9 kg (197.8 pounds)
Reactions: Pharyngeal Inflammation, Hypoxia, Caecitis, Rash Maculo-Papular, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-28
Cefepime
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-22
Daunorubicin HCL
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-22
Cytarabine
Dosage: unk
Start date: 2012-05-18
End date: 2012-05-18
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-26
Possible Velcade side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22
Patient: male
Reactions: Vomiting, Renal Disorder, Ileus, Nausea, Constipation
Drug(s) suspected as cause:
Velcade
Dosage: unk
Indication: Multiple Myeloma
Revlimid
Dosage: unk
Indication: Multiple Myeloma
Dexamethasone
Dosage: unk
Indication: Multiple Myeloma
Possible Velcade side effects in female
Reported by a physician from Japan on 2012-08-22
Patient: female, weighing 51.0 kg (112.2 pounds)
Reactions: Cheyne-Stokes Respiration, Cardiac Failure, Pain, Depressed Level of Consciousness, Platelet Count Decreased, Cardiac Amyloidosis, Liver Disorder
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Velcade
Start date: 2012-03-26
Velcade
Start date: 2012-03-19
Velcade
Indication: Multiple Myeloma
End date: 2012-04-19
Velcade
Indication: Renal Amyloidosis
Start date: 2012-03-23
Velcade
End date: 2012-04-19
Velcade
Start date: 2012-03-19
Velcade
End date: 2012-04-12
Velcade
Start date: 2012-03-23
Velcade
Start date: 2012-03-26
Velcade
End date: 2012-04-12
Velcade
Start date: 2012-03-26
Velcade
Start date: 2012-03-16
Velcade
Start date: 2012-03-23
Fentanyl-100
Indication: Cancer Pain
Start date: 2012-04-25
End date: 2012-04-25
Velcade
End date: 2012-04-16
Velcade
End date: 2012-04-12
Velcade
End date: 2012-04-09
Velcade
Start date: 2012-03-16
Velcade
End date: 2012-04-09
Velcade
Start date: 2012-03-19
Velcade
End date: 2012-04-09
Velcade
End date: 2012-04-16
Velcade
Indication: Cardiac Amyloidosis
End date: 2012-04-19
Velcade
End date: 2012-04-16
Velcade
Start date: 2012-03-16
Other drugs received by patient: Zyvox; Dopamine HCL; Carvedilol; Tolvaptan; Losartan Potassium; Amiodarone HCL; Dexamethasone Acetate; Lasix; Albumin (Human); Lasix; Azosemide; Forsenid; Trichlormethiazide; Valtrex; Fentanyl Citrate; Azosemide; Eplerenone; AN Unknown Medication; Losartan Potassium; Omeprazole
Possible Velcade side effects in
Reported by a physician from Spain on 2012-08-22
Patient:
Reactions: Gastrointestinal Hypomotility, Respiratory Tract Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Dosage: 1.98 mg, unk
Indication: Multiple Myeloma
Start date: 2011-04-11
End date: 2012-06-06
Melphalan Hydrochloride
Dosage: 14 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-04-11
End date: 2011-06-02
Prednisone TAB
Dosage: 90 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-04-11
End date: 2011-06-02
Possible Velcade side effects in
Reported by a physician from France on 2012-08-22
Patient:
Reactions: Lung Disorder
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Dosage: 180 mg, qd
Indication: Mantle Cell Lymphoma
Start date: 2012-05-29
End date: 2012-05-30
Mabthera
Dosage: 750 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2012-05-29
End date: 2012-05-29
Velcade
Dosage: 2.6 mg, qd
Indication: Mantle Cell Lymphoma
Start date: 2012-05-29
End date: 2012-06-08
Dexamethasone
Dosage: 40 mg, unk
Indication: Mantle Cell Lymphoma
Other drugs received by patient: Rocephin; Glucophage; Fasturtec; Lasix; Duphalac; Colchicine; Actrapid / 00030501 /; Xanax; Ventolin; Albumin; Atarax; Nexium; Zelitrex / 01269701 /; Tranxene; Bactrim; Imovane; Magnesium Sulfate; Ramipril; Citalopram Hydrobromide; Folic Acid; Oxazepam; Pentoxifylline; Lasix
Possible Velcade side effects in
Reported by a physician from Netherlands on 2012-08-22
Patient:
Reactions: Pneumonia, Pain
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-12-23
End date: 2012-01-03
Cyclophosphamide
Dosage: 4000 mg/m2, unk
Start date: 2012-02-03
End date: 2012-02-03
Velcade
Dosage: 1.3 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2011-12-23
End date: 2012-01-02
Cyclophosphamide
Dosage: 500 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2011-12-23
End date: 2011-12-30
Other drugs received by patient: Tramal / 00599201 /; Acetaminophen; Ascal / 00002702 /; Oxycodone HCL; Fluconazole; Gabapentin; Persantine; Haldol; Omeprazole; Butrans; Fragmin; Esomeprazole Sodium; Pregabalin; Cotrim; Valaciclovir; Hydrochlorothiazide
Possible Velcade side effects in male
Reported by a physician from United States on 2012-08-22
Patient: male
Reactions: Haemorrhage
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Page 1 Next >>
|